disease

New York City’s health department has reported a fourth death in connection with a Legionnaires’ disease outbreak in Manhattan’s Upper East Side. Multiple deaths have been reported in the past…

BeritK/iStock via Getty Images The US FDA has granted Fast Track designation to Acadia Pharmaceuticals’ (ACAD) remlifanserin in Alzheimer’s disease psychosis. The asset is currently in phase 2 for Lewy…

A Legionnaires’ disease outbreak has been reported in Manhattan, stoking fears as the number of cases — which currently sits at 18 — continues to grow. Here’s what to know…

“I’m retired and 72.”

Investor Insight Cardiol Therapeutics is positioned with a late-stage lead asset, multiple orphan indications, strong clinical proof-of-concept data, and a differentiated non-immunosuppressive approach to inflammatory heart disease. The company’s 2025–2026…

“We have a 401(k) with $20,000, and $29,000 in a Roth IRA.”